Review Article on Aspirin for prevention of cancer-A potential!
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2017, Vol 6, Issue 4
Abstract
Cancer has been a worldwide threat now with millions of cases of morbidity and mortality owing to it. According to the World Health Organization (WHO), cancer accounted for 8.2 million deaths worldwide by 2012 and its prevalence is predicted to increase in the next decade. There are, however, new data that reinforce the notion that low-dose aspirin intake may also help to prevent cancer and prevent the multiplying of cancer cells. Over the last few years, many studies have combated or supported the substantiation of the relationship between aspirin and cancer that have awakened the interest of researchers in this area. Many studies with follow-up period as long as 20 years have been carried out to analyze the effect that regular use of low-dose aspirin (75-300mg) can have on cancer prevention, especially colorectal cancer and the results have been promising. With the comprehensive analysis of risks and benefits and the linking evidences showing that aspirin, at low doses, can lower the risk of developing colorectal cancer by 40%, the U.S. Preventive Services Task Force (USPSTF) in 2015 released a draft recommendation around the use of aspirin to help prevent cardiovascular disease and colorectal cancer. The guidance was later released in April 2016. By far, there have been evidences for both COX-dependent and COX-independent mechanisms in aspirin cancer prevention. Based on the data that we have from various RCT’s and pharmacovigilance sources, the safety profile of aspirin looks reasonably good with the most commonly reported adverse event being Gastrointestinal bleeding. Although some clinical trials have shown that the risk may only be modest it however, cannot be ignored
Authors and Affiliations
Riju Pathak| Pharm.D, Krupanidhi College of Pharmacy, Chikka Bellandur, Carmellaram Post, Varthur Hobli, Bangalore-35, Patel Trushitkumar B| Pharm.D, Krupanidhi College of Pharmacy, Chikka Bellandur, Carmellaram Post, Varthur Hobli, Bangalore-35
Keywords
Related Articles
- EP ID EP4151
- DOI -
- Views 431
- Downloads 23
THE APPLICATION OF PROBIOTICS IN DECREASE CANCER
Cancer is one of the most important deaths causing in the world and many factors as chemicals, rays, viruses and genetic factors may influence it. Probiotics, live cells with different beneficiary characteristics, have b...
IDENTIFICATION OF CLINICALLY RELEVANT MYCOBACTERIUM OTHER THAN TUBERCULOSIS (MOTT) SPECIES BY REAL-TIME PCR COUPLED WITH A HIGH-RESOLUTION MELTING SYSTEM
A real-time PCR coupled with a high-resolution melting curve assay for identifying clinically relevant MOTT species was developed and evaluated using 6 reference strains and 186 Culture isolates. Concordant results were...
EVALUATION OF THE SIGNALLING MECHANISMS OF LYSOPHOSPHATIDIC ACID AND ITS ROLE IN THE CENTRAL NERVOUS SYSTEM
Lysophosphatidic acid (LPA), which is proposed to play an important role in normal physiological situations such as wound healing, maintenance of vascular tone, vascular integrity and reproduction, may also be implicated...
Evaluation of Brain Targeting of Drugs after Administered Intranasally
Intranasal route has potential to target brain and possesses several advantages over parenteral and oral routes in treating CNS disorders such as stroke, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, epil...
Cervical Cancer–A Review Article
Cervical Cancer is malignant Carcinoma type of cancer originate in cervix region. The cervix is the narrow portion of the uterus where it joins with the top of the vagina. Most cervical cancers are squamous cell carcinom...